All analyses
5 min read

Last updated:

Creatine after 50: what supplementation really adds, and under what conditions

Creatine is the best documented supplement on the market, and also one of the most poorly used. Its effect exists, it is modest, and it depends almost entirely on two things: the presence of resistance training, and the regularity of intake. The rest is mostly belief.

9 studies citedsee the sources

Benjamin Sant

Co-founder of the School of Longevity

Strength work and muscle mass
Strength work and muscle mass

The effect exists, but it is conditioned on resistance training

The exact wording matters. A meta-analysis on older adults concludes that creatine combined with a resistance program increases lean mass and strength compared with placebo. The combination is the important word: the trials included compare creatine plus training against placebo plus training. No solid data support isolated intake in a sedentary person.

Heterogeneity between individual trials is substantial, and the authors attribute it largely to intake strategies. A loading phase followed by a low dose, 5 g per day or less, improves bench press strength compared with placebo. A higher dose, above 5 g per day, with or without a loading phase, improves leg press strength.

The most useful detail is negative. When trials with a loading phase are removed from the analysis, creatine no longer does better than placebo on bench press or leg press. And intake limited to training days is not enough. The question asked in consultation, should I take some, is therefore badly framed: the real question is how, and how regularly.

Strength gains depend on training level and dose

A 2025 meta-analysis focused specifically on muscle strength adds three useful nuances. No strength difference existed at baseline between the creatine group and the control group, and the creatine group progressed significantly more after the intervention. The effect is therefore attributable to supplementation and not to an initial imbalance.

Untrained people progress more than trained people. That is consistent with what is observed for most interventions: the room for progression determines the size of the gain. For a practitioner coaching sedentary adults who are starting again, that is good news, provided you do not promise a confirmed athlete the same effect.

Low to moderate doses do better than high doses, and high intensity training benefits more from supplementation. So there is no increasing relation between the amount ingested and the result. Raising the dose above what the trials use is not an optimization, it is an expense.

On cognition, the signal is real but narrow

A systematic review with meta-analysis from 2024 retained sixteen randomized trials and 492 participants, aged 20.8 to 76.4 years, healthy people and patients combined. All trials used creatine monohydrate, which makes interpretation easier.

The significant effects concern memory, standardized mean difference of 0.31, attention time and information processing speed. These are small effects by usual conventions, measured on laboratory tests.

By contrast, no significant improvement appears on global cognitive function. Presenting creatine as a strategy to prevent cognitive decline therefore goes far beyond what these data allow. A practitioner can mention a signal on memory, provided they state the size and the nature of the measures.

Safety is one of the best documented points, and one of the most misunderstood

The kidney fear comes up in almost every consultation. A double blind placebo controlled trial followed strength trainees supplemented at 0.3 g per kilo per day for seven days, with 41 blood and urine parameters measured before and thirty days after. No adverse event, no change in kidney or liver function, no change in lipid profile or blood count.

The weight gain observed is expected and does not reflect an adverse effect: it corresponds to intramuscular water retention linked to the increase in the creatine store. Explaining it in advance avoids stopping the product after three weeks because the scale moved.

Hair loss is the most widespread fear and the least founded. A 2025 randomized trial followed 45 trained men for twelve weeks receiving 5 g per day of monohydrate or a placebo, with total and free testosterone, dihydrotestosterone, and hair density assessed by trichogram and imaging. No group by time interaction was observed, either on hormones or on hair parameters.

Monohydrate, and nothing else

The market offers forms presented as better absorbed or more stable. A double blind trial compared monohydrate with a derivative, creatyl-L-leucine, by measuring muscle creatine content directly. Only monohydrate increased that content.

That is a direct measure of the mechanism, not a performance criterion, and that is precisely what makes it decisive. A form that does not raise the intramuscular store cannot produce the expected effect, whatever the quality of the commercial argument.

The practical consequence is simple and economical. Monohydrate is the form used in almost all positive trials, including those on cognition, and it is the cheapest. Pointing people toward anything else amounts to charging more for a product whose effect is not demonstrated, which is exactly the criticism aimed at the so called anti-aging supplement market.

How to talk about it in coaching, and where the practitioner's role stops

Creatine is only of interest within a plan that already includes regular strength work. Presenting it before training has been established reverses the order of levers, and is the best way to obtain no measurable result. The priority remains maintaining muscle mass and strength with age, to which creatine adds a marginal contribution.

The markers drawn from the trials are a single form, monohydrate, daily intake not limited to training days, a low to moderate dose, and a horizon of several weeks before any evaluation. Measuring strength again on a simple and reproducible test, rather than judging by feel, is part of the work.

Three situations require handing over to the physician before any supplementation: known or suspected kidney disease, ongoing nephrotoxic treatment, and pregnancy or breastfeeding, for which data are lacking. The available work covers healthy populations, and a trial in young adults says nothing about a weakened terrain.

Sources

  1. 1.Forbes SC, et al. Meta-Analysis Examining the Importance of Creatine Ingestion Strategies on Lean Tissue Mass and Strength in Older Adults. Nutrients. 2021.
  2. 2.Zhang H, et al. Effects of creatine supplementation on muscle strength gains, a meta-analysis and systematic review. PeerJ. 2025.
  3. 3.Xu C, et al. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr. 2024.
  4. 4.Lak M, et al. Does creatine cause hair loss? A 12-week randomized controlled trial. J Int Soc Sports Nutr. 2025.
  5. 5.Kreider RB, Stout JR. Creatine in Health and Disease. Nutrients. 2021.
  6. 6.Almeida D, et al. Creatine supplementation improves performance, but is it safe? Double-blind placebo-controlled study. J Sports Med Phys Fitness. 2020.
  7. 7.Askow AT, et al. Creatine Monohydrate Supplementation, but not Creatyl-L-Leucine, Increased Muscle Creatine Content in Healthy Young Adults. J Diet Suppl. 2022.
  8. 8.Desai I, et al. The Effect of Creatine Supplementation on Resistance Training-Based Changes to Body Composition: A Systematic Review and Meta-analysis. Sports Med. 2024.
  9. 9.Burke R, et al. The Effects of Creatine Supplementation Combined with Resistance Training on Regional Measures of Muscle Hypertrophy: A Systematic Review with Meta-Analysis. Nutrients. 2023.

Reading studies is one thing, turning them into a plan is another

The Longevity Practitioner certification teaches the method that turns this kind of data into an accompaniment decision: assess, prioritise, plan over 90 days, re-measure, and know when to hand over.

See the certification

11 modules, €2,200. Enrol

Benjamin Sant

Co-founder of the School of Longevity

Cofounder of the School of Longevity with Tristan Maruyama. A former officer trained at Saint-Cyr from 2019 to 2022 and a coach since 2018, he has supported more than 4,000 people. He leads the School's editorial content with one constant principle: pass on only what can be situated, verified and applied seriously.

This article is published for information and education. It does not replace medical advice. For any personal health question, consult a healthcare professional.